API & Intermediates
Excel Pharmaceuticals division manufactures a range of penultimate-stage pharmaceutical intermediates and APIs for the healthcare industry. Building on Excel’s famed process research and chemical technology prowess, we now bring to India an extremely reliable and competitive alternative to imported inputs.
We have a dedicated API manufacturing plant at Excel’s ISO 9001:2008 certified facilities at Lote. Spread over 100,000 sq ft our plant is fully compliant with cGMP. The API plant operates independently from Excel’s dedicated veterinary facility at Roha.
Our focus on backward integration sets us apart. We ensure consistent quality by sourcing inputs and intermediates in-house down to the base molecule stage. This self-sufficiency also helps us serve our clients better through the ups and downs in international markets.
Nurturing long-term relationships is the Excel way. We are committed to building relationships with our clients and grow with them. With this vision, we are ready for the market with a wide range of products and more in the pipeline and our determination to make a difference.
API
Febuxostat-API & Intermediates
Febuxostat API- CAS No. 144060-53-7
Therapeutic Category- Antihyperuricemia (for treatment of Gout)
Intermediates
Name | CAS No. |
---|---|
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate (T5) | 160844-75-7 |
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate (T4) | 161798-03-4 |
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4 -methythiazole-5-carboxylate (T3) | 161798-01-2 |
Ethyl 2-(4-hydroxyphenyl)-4 –methyl-1, 3-thiazole-5-carboxylate (T2) | 161797-99-5 |
4-Hydroxybenzenecarbothioamide (T1) | 25984-63-8 |
Ethyl 4-methyl-1,3-thiazole-5-carboxylate | 20582-55-2 |
Ethyl-2-chloroacetoacetate | 609-15-4 |
Sitagliptin API & Intermediates
Sitagliptin API- CAS No. 654671-77-9
Therapeutic Category: An Anti-diabetic Medication used to treat Type -2 Diabetes
Intermediates
Name | CAS No. |
---|---|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
4-Oxo-4-[3-(trifluoroMethyl)-5,6-dihydro-[1,2,4] triazolol [4,3-a] pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one (Ketoamide) | 764667-65-4 |
Vidagliptin API& Intermediates
Vidagliptin API- CAS No. 654671-77-9
Therapeutic Category: An Anti-diabetic Medication used to treat Type -2 Diabetes
Intermediates
Name | CAS No. |
---|---|
1-(2-Chloroacetyl)-(2S)-pyrrolidine Carbonitrile | 207557-35-5 |
3-Amino-1- adamantanol | 702-82-9 |
Teneligliptin Hemipenta Hydrobromide Hydrate-
CAS No. : 1572583-29-9
Therapeutic Category: “DPP-4 inhibitors” or “Gliptins”- class of anti-diabetic drug
Intermediates
Name | CAS No. |
---|---|
1-(3-methyl-1-phenyl-1H-pyrazol-5-yl) piperazine (PPZ) | 401566-79-8 |
(2S) -4-Oxo-2-(3 thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid | 401564-36-1 |
Acotiamide Hydrochloride Hydrate
CAS No. : 773092-05-0
Therapeutic Category: Treatment of functional dyspepsia (Indigestion)
Intermediates
Name | CAS No. |
---|---|
Ethyl-2-amino-1, 3-thaizole-4 carboxylate | 5398-36-7 |
Veterinary API
We are Excel Veterinary Healthcare, manufacturer of a wide range of high-quality veterinary APIs and part of the Excel group. Taking forward Excel’s decades long partnership with farmers and agriculturists in improving crop yields, we bring the same innovation and passion into veterinary healthcare.
Quality and client focus has always been Excel’s signature throughout our 70 years of operation. To ensure compliance, we have set up a dedicated GMP plant for manufacturing veterinary APIs.
Our plant has been licenced by the Maharashtra state FDA and embraces the highest manufacturing standards.
Through in-house process development, we have created a wide range of APIs ready to market and have a strong pipeline under development.
Our long-term vision is to make a positive impact on the veterinary industry through APIs that comply with global standards It is our mission to serve the needs of the veterinary API industry in every way.
Product: Butaphosphan
CAS No. : 17316-67-5
Therapeutic category: Phosphorus Supplementation